Rtw Investments as of March 31, 2017
Portfolio Holdings for Rtw Investments
Rtw Investments holds 28 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals (ALNY) | 14.7 | $56M | 1.1M | 51.25 | |
| Avexis | 12.5 | $47M | 623k | 76.03 | |
| Bristol Myers Squibb (BMY) | 8.2 | $31M | 571k | 54.38 | |
| La Jolla Pharmaceuticl Com Par | 8.1 | $31M | 1.0M | 29.85 | |
| BioCryst Pharmaceuticals (BCRX) | 7.7 | $29M | 3.5M | 8.40 | |
| Medicines Company | 7.4 | $28M | 573k | 48.90 | |
| Regenxbio Inc equity us cm (RGNX) | 6.2 | $24M | 1.2M | 19.30 | |
| Atara Biotherapeutics | 4.9 | $19M | 909k | 20.55 | |
| Agenus | 4.2 | $16M | 4.2M | 3.77 | |
| Ptc Therapeutics I (PTCT) | 3.4 | $13M | 1.3M | 9.84 | |
| Incyte Corporation (INCY) | 2.9 | $11M | 83k | 133.66 | |
| Oxford Immunotec Global | 2.5 | $9.5M | 613k | 15.49 | |
| Bluebird Bio | 2.5 | $9.4M | 104k | 90.90 | |
| Masimo Corporation (MASI) | 2.0 | $7.5M | 81k | 93.26 | |
| OraSure Technologies (OSUR) | 1.9 | $7.3M | 566k | 12.93 | |
| Viveve Med | 1.9 | $7.3M | 1.1M | 6.33 | |
| Dicerna Pharmaceuticals | 1.9 | $7.0M | 2.1M | 3.40 | |
| Corium Intl | 1.6 | $6.1M | 1.4M | 4.18 | |
| Tactile Systems Technology, In (TCMD) | 1.4 | $5.5M | 288k | 18.95 | |
| Arbutus Biopharma (ABUS) | 1.2 | $4.7M | 1.4M | 3.25 | |
| Viewray (VRAYQ) | 1.2 | $4.4M | 516k | 8.51 | |
| Invuity | 1.0 | $3.7M | 470k | 7.95 | |
| Global Blood Therapeutics In | 0.2 | $965k | 26k | 36.86 | |
| Celldex Therapeutics | 0.2 | $873k | 242k | 3.61 | |
| Biopharmx | 0.2 | $642k | 1.3M | 0.50 | |
| Sensus Healthcare (SRTS) | 0.1 | $397k | 90k | 4.39 | |
| Natera (NTRA) | 0.1 | $281k | 32k | 8.87 | |
| Sensus Healthcare Inc Wrt Exp | 0.0 | $136k | 155k | 0.88 |
